Synopsis
0
VMF
DRUG PRODUCT COMPOSITIONS0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - CREAM;TOPICAL - 0.05% **Federal Regi...DOSAGE - CREAM;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 20340
DOSAGE - CREAM;TOPICAL - 0.025%
USFDA APPLICATION NUMBER - 209483
DOSAGE - AEROSOL, FOAM;TOPICAL - 0.05% **Fede...DOSAGE - AEROSOL, FOAM;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 21142
DOSAGE - LOTION;TOPICAL - 0.05%
USFDA APPLICATION NUMBER - 213691
DOSAGE - LOTION;TOPICAL - 0.05%
USFDA APPLICATION NUMBER - 21535
DOSAGE - SHAMPOO;TOPICAL - 0.05%
USFDA APPLICATION NUMBER - 21644
DOSAGE - AEROSOL, FOAM;TOPICAL - 0.05% **Fede...DOSAGE - AEROSOL, FOAM;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 22013
Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kirsch Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dr. Paul Lohmann GmbH & Co. KGaA
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CD Formulation
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Clariant
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Esteem Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gloria Interchem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lubrizol Life Science Health
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qianhao Chemical (Hebei) Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Topical
Coating Systems & Additives
Solubilizers
Thickeners and Stabilizers
Controlled & Modified Release
Parenteral
Emulsifying Agents
Surfactant & Foaming Agents
Film Formers & Plasticizers
API Stability Enhancers
Granulation
Taste Masking
Direct Compression
Empty Capsules
Rheology Modifiers
Vegetarian Capsules
Fillers, Diluents & Binders
Lubricants & Glidants
Coloring Agents
Co-Processed Excipients
Chewable & Orodispersible Aids
Disintegrants & Superdisintegrants
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
US Patents
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
78
PharmaCompass offers a list of Clobetasol Propionate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Clobetasol Propionate manufacturer or Clobetasol Propionate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Clobetasol Propionate manufacturer or Clobetasol Propionate supplier.
PharmaCompass also assists you with knowing the Clobetasol Propionate API Price utilized in the formulation of products. Clobetasol Propionate API Price is not always fixed or binding as the Clobetasol Propionate Price is obtained through a variety of data sources. The Clobetasol Propionate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Clobetasol-17-propionate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clobetasol-17-propionate, including repackagers and relabelers. The FDA regulates Clobetasol-17-propionate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clobetasol-17-propionate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Clobetasol-17-propionate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Clobetasol-17-propionate supplier is an individual or a company that provides Clobetasol-17-propionate active pharmaceutical ingredient (API) or Clobetasol-17-propionate finished formulations upon request. The Clobetasol-17-propionate suppliers may include Clobetasol-17-propionate API manufacturers, exporters, distributors and traders.
click here to find a list of Clobetasol-17-propionate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Clobetasol-17-propionate DMF (Drug Master File) is a document detailing the whole manufacturing process of Clobetasol-17-propionate active pharmaceutical ingredient (API) in detail. Different forms of Clobetasol-17-propionate DMFs exist exist since differing nations have different regulations, such as Clobetasol-17-propionate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Clobetasol-17-propionate DMF submitted to regulatory agencies in the US is known as a USDMF. Clobetasol-17-propionate USDMF includes data on Clobetasol-17-propionate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Clobetasol-17-propionate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Clobetasol-17-propionate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Clobetasol-17-propionate Drug Master File in Japan (Clobetasol-17-propionate JDMF) empowers Clobetasol-17-propionate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Clobetasol-17-propionate JDMF during the approval evaluation for pharmaceutical products. At the time of Clobetasol-17-propionate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Clobetasol-17-propionate suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Clobetasol-17-propionate Drug Master File in Korea (Clobetasol-17-propionate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Clobetasol-17-propionate. The MFDS reviews the Clobetasol-17-propionate KDMF as part of the drug registration process and uses the information provided in the Clobetasol-17-propionate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Clobetasol-17-propionate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Clobetasol-17-propionate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Clobetasol-17-propionate suppliers with KDMF on PharmaCompass.
A Clobetasol-17-propionate CEP of the European Pharmacopoeia monograph is often referred to as a Clobetasol-17-propionate Certificate of Suitability (COS). The purpose of a Clobetasol-17-propionate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Clobetasol-17-propionate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Clobetasol-17-propionate to their clients by showing that a Clobetasol-17-propionate CEP has been issued for it. The manufacturer submits a Clobetasol-17-propionate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Clobetasol-17-propionate CEP holder for the record. Additionally, the data presented in the Clobetasol-17-propionate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Clobetasol-17-propionate DMF.
A Clobetasol-17-propionate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Clobetasol-17-propionate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Clobetasol-17-propionate suppliers with CEP (COS) on PharmaCompass.
A Clobetasol-17-propionate written confirmation (Clobetasol-17-propionate WC) is an official document issued by a regulatory agency to a Clobetasol-17-propionate manufacturer, verifying that the manufacturing facility of a Clobetasol-17-propionate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Clobetasol-17-propionate APIs or Clobetasol-17-propionate finished pharmaceutical products to another nation, regulatory agencies frequently require a Clobetasol-17-propionate WC (written confirmation) as part of the regulatory process.
click here to find a list of Clobetasol-17-propionate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Clobetasol-17-propionate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Clobetasol-17-propionate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Clobetasol-17-propionate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Clobetasol-17-propionate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Clobetasol-17-propionate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Clobetasol-17-propionate suppliers with NDC on PharmaCompass.
Clobetasol-17-propionate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Clobetasol-17-propionate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Clobetasol-17-propionate GMP manufacturer or Clobetasol-17-propionate GMP API supplier for your needs.
A Clobetasol-17-propionate CoA (Certificate of Analysis) is a formal document that attests to Clobetasol-17-propionate's compliance with Clobetasol-17-propionate specifications and serves as a tool for batch-level quality control.
Clobetasol-17-propionate CoA mostly includes findings from lab analyses of a specific batch. For each Clobetasol-17-propionate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Clobetasol-17-propionate may be tested according to a variety of international standards, such as European Pharmacopoeia (Clobetasol-17-propionate EP), Clobetasol-17-propionate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Clobetasol-17-propionate USP).
